- Report
- July 2024
- 35 Pages
Mexico
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 35 Pages
Japan
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 39 Pages
China
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 38 Pages
South Korea
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 37 Pages
Russia
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 37 Pages
Spain
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 39 Pages
Italy
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 36 Pages
United Kingdom
From €4767EUR$4,995USD£3,994GBP
- Report
- May 2024
- 275 Pages
Global
From €3407EUR$3,570USD£2,855GBP
The Circulatory Support Device market is a subset of the Cardiovascular Devices market, which includes a range of products used to diagnose and treat cardiovascular diseases. Circulatory Support Devices are used to provide temporary or permanent support to the heart and/or lungs, and can be used to treat a variety of conditions, including heart failure, pulmonary hypertension, and cardiogenic shock. These devices are typically implanted, and can include ventricular assist devices, extracorporeal membrane oxygenation (ECMO) systems, and total artificial hearts.
Circulatory Support Devices are used in both acute and chronic settings, and are typically used in conjunction with other treatments, such as medications and lifestyle changes. The market is expected to grow in the coming years, driven by an aging population and increasing prevalence of cardiovascular diseases.
Notable companies in the Circulatory Support Device market include Abiomed, Medtronic, Berlin Heart, SynCardia Systems, and HeartWare International. Show Less Read more